These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 3520603)

  • 21. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
    Tedford CE; Crosby G; Iorio LC; Chipkin RE
    Eur J Pharmacol; 1992 Feb; 211(2):169-76. PubMed ID: 1535318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rewarding brain stimulation: role of tegmental cholinergic neurons that activate dopamine neurons.
    Yeomans JS; Mathur A; Tampakeras M
    Behav Neurosci; 1993 Dec; 107(6):1077-87. PubMed ID: 8136061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GBR 12909 reverses the SCH 23390 inhibition of rewarding effects of brain stimulation.
    Rompré PP; Bauco P
    Eur J Pharmacol; 1990 Jun; 182(1):181-4. PubMed ID: 1976096
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissociation of the attentional and motivational effects of pimozide on the threshold for rewarding brain stimulation.
    Bird M; Kornetsky C
    Neuropsychopharmacology; 1990 Feb; 3(1):33-40. PubMed ID: 2137697
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Facilitation of self-stimulation of ventral tegmentum by microinjection of opioid receptor subtype agonists.
    Singh J; Desiraju T; Nagaraja TN; Raju TR
    Physiol Behav; 1994 Apr; 55(4):627-31. PubMed ID: 7910690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockade of substantia nigra dopamine D1 receptors reduces intravenous cocaine reward in rats.
    Quinlan MG; Sharf R; Lee DY; Wise RA; Ranaldi R
    Psychopharmacology (Berl); 2004 Aug; 175(1):53-9. PubMed ID: 14767633
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A dopamine D1 agonist elevates self-stimulation thresholds: comparison to other dopamine-selective drugs.
    Baldo BA; Jain K; Veraldi L; Koob GF; Markou A
    Pharmacol Biochem Behav; 1999 Apr; 62(4):659-72. PubMed ID: 10208371
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopamine and glutamate release in the nucleus accumbens and ventral tegmental area of rat following lateral hypothalamic self-stimulation.
    You ZB; Chen YQ; Wise RA
    Neuroscience; 2001; 107(4):629-39. PubMed ID: 11720786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of D1/D2 dopamine receptors in the CA1 region of the rat hippocampus in the rewarding effects of morphine administered into the ventral tegmental area.
    Esmaeili MH; Kermani M; Parvishan A; Haghparast A
    Behav Brain Res; 2012 May; 231(1):111-5. PubMed ID: 22426507
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Significance of CRF and dopamine receptors in amygdala for reinforcing effects of opiates and opioids on self-stimulation of lateral hypothalamus in rats].
    Shabanov PD; Lebedev AA; Liubimov AV; Kornilov VA
    Eksp Klin Farmakol; 2011; 74(7):3-8. PubMed ID: 21894759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Contrasting effects of dopamine antagonists and frequency reduction on Fos expression induced by lateral hypothalamic stimulation.
    Hunt GE; McGregor IS
    Behav Brain Res; 2002 May; 132(2):187-201. PubMed ID: 11997149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The extended amygdala system and self-stimulation of the lateral hypothalamus in rats: modulation with opiates and opioids].
    Shabanov PD; Lebedev AA
    Ross Fiziol Zh Im I M Sechenova; 2011 Feb; 97(2):180-8. PubMed ID: 21598678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cholinergic antagonists in ventral tegmentum elevate thresholds for lateral hypothalamic and brainstem self-stimulation.
    Kofman O; Yeomans JS
    Pharmacol Biochem Behav; 1988 Nov; 31(3):547-59. PubMed ID: 3251239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of isolation-rearing on intracranial self-stimulation reward of the lateral hypothalamus: baseline assessment and drug challenges.
    Sundstrom JM; Hall FS; Stellar JR; Waugh EJ
    Life Sci; 2002 Apr; 70(23):2799-810. PubMed ID: 12269384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The putative dopamine D3 agonist, 7-OH-DPAT, reduces dopamine release in the nucleus accumbens and electrical self-stimulation to the ventral tegmentum.
    Gilbert DB; Millar J; Cooper SJ
    Brain Res; 1995 May; 681(1-2):1-7. PubMed ID: 7552265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects of systemic and intracerebral injections of D1 and D2 agonists on brain stimulation reward.
    Ranaldi R; Beninger RJ
    Brain Res; 1994 Jul; 651(1-2):283-92. PubMed ID: 7922577
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo release of [3H]gamma-aminobutyric acid in the rat neostriatum--II. Opposing effects of D1 and D2 dopamine receptor stimulation in the dorsal caudate putamen.
    Girault JA; Spampinato U; Glowinski J; Besson MJ
    Neuroscience; 1986 Dec; 19(4):1109-17. PubMed ID: 2950336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. D-2 dopamine antagonist-like effects of SCH 23390 on A9 and A10 dopamine neurons.
    Goldstein JM; Litwin LC; Sutton EB; Malick JB
    Life Sci; 1987 Mar; 40(11):1039-44. PubMed ID: 2950291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Amphetamine-like stimulus properties produced by electrical stimulation of reward sites in the ventral tegmental area.
    Druhan JP; Fibiger HC; Phillips AG
    Behav Brain Res; 1990 May; 38(2):175-84. PubMed ID: 2163647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reward summation and the effects of dopamine D1 and D2 agonists and antagonists on fixed-interval responding for brain stimulation.
    Hunt GE; Atrens DM; Jackson DM
    Pharmacol Biochem Behav; 1994 Aug; 48(4):853-62. PubMed ID: 7972288
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.